EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure

Zhongqiao Lu, Shuizhen Shi, Fan Xia, Adwaid Manu Krishna Chandran, Jonathan Lin, Daniela J Iniguez, Massoud Motamedi, Hua Liu, Wenbo Zhang

Molecular Therapy · 2026-11 · 34 (11) · 6634-6656

DOI: 10.1016/j.ymthe.2026.08.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Zhongqiao Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Neurosciences, University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Mechlorethamine, Transcription Factors, Corneal Injuries, Cell Cycle Proteins. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal chemical injury, including mustard vesicant injury, remains a clinical challenge with limited therapeutic options. To enable effective mechanistic and therapeutic studies, we developed a mouse model of nitrogen mustard (NM)-induced corneal injury using a 3D-molded, cap-shaped filter paper conforming to the corneal surface to generate reproducible injuries. Multimodal in vivo imaging and histological assessment revealed an injury course characterized by acute epithelial disruption, stromal edema, and inflammation, followed by transient partial recovery and chronic stromal remodeling with persistent endothelial loss. After NM exposure, bromodomain (BD)-containing protein 4 (BRD4) expression and activity were upregulated. Short-term topical BRD4 inhibition with JQ1 reduced acute corneal inflammation (e.g., reducing CD45+ cells by 86%) and oxidative stress and conferred long-term preservation of corneal clarity, stromal organization, and endothelial integrity. Selective inhibition of BD1 or BD2 recapitulated JQ1's effects, indicating that blockade of either BD is sufficient. BRD4 inhibition also significantly attenuated NM-induced corneal pathology in a rabbit model, supporting cross-species efficacy and translational relevance. Mechanistically, BRD4 inhibition selectively counteracted key NM-driven pathogenic programs, including inflammation, oxidative stress, and extracellular matrix remodeling. These findings identify BRD4 as a central epigenetic driver of vesicant-induced corneal injury and position BRD4 inhibition as a promising translational therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MechlorethamineTranscription FactorsCorneal InjuriesCell Cycle ProteinsAzepinesTriazolesAnimalsBromodomain Containing ProteinsMiceDisease Models, AnimalRabbitsHumansCorneaOxidative StressNuclear Proteins

Stichwörter der Autor:innen

BRD4ECM remodelingcorneal chemical injuryendothelial damageinflammationlive imagingneovascularizationnitrogen mustard

Substanzen

MechlorethamineTranscription FactorsBromodomain Containing ProteinsCell Cycle ProteinsBrd4 protein, mouseAzepinesTriazoles(+)-JQ1 compoundNuclear Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology & Visual Neurosciences, University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Department of Ophthalmology & Visual Neurosciences, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: hualiu@utmb.edu.
  • Department of Ophthalmology & Visual Neurosciences, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Neurobiology, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic addr…

Förderung

  • NEI NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases
  • National Eye Institute

Zitieren

APA

Lu, Z., Shi, S., Xia, F., Krishna Chandran, A. M., Lin, J., Iniguez, D. J., Motamedi, M., Liu, H., & Zhang, W. (2026). BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure. Molecular Therapy, 34(11), 6634-6656. https://doi.org/10.1016/j.ymthe.2026.08.045

Vancouver

Lu Z, Shi S, Xia F, Krishna Chandran AM, Lin J, Iniguez DJ, et al. BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure. Molecular Therapy. 2026;34(11):6634-6656. doi:10.1016/j.ymthe.2026.08.045

BibTeX
@article{Lu2026,
  author = {Lu, Zhongqiao and Shi, Shuizhen and Xia, Fan and Krishna Chandran, Adwaid Manu and Lin, Jonathan and Iniguez, Daniela J and Motamedi, Massoud and Liu, Hua and Zhang, Wenbo},
  title = {BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposure},
  journal = {Molecular Therapy},
  year = {2026},
  volume = {34},
  number = {11},
  pages = {6634--6656},
  doi = {10.1016/j.ymthe.2026.08.045}
}
Kostenlos starten →